RSB Spine, LLC v. DePuy Synthes Sales, Inc.

CourtDistrict Court, D. Delaware
DecidedJanuary 7, 2025
Docket1:19-cv-01515
StatusUnknown

This text of RSB Spine, LLC v. DePuy Synthes Sales, Inc. (RSB Spine, LLC v. DePuy Synthes Sales, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
RSB Spine, LLC v. DePuy Synthes Sales, Inc., (D. Del. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

RSB SPINE, LLC, Plaintiff/Counter-Defendant, y Civil Action No. 19-01515-RGA

DEPUY SYNTHES SALES, INC., and DEPUY SYNTHES PRODUCTS, INC., Defendants/Counter-Plaintiffs.

MEMORANDUM OPINION John C. Phillips, Jr., David A. Bilson, PHILLIPS, MCLAUGHLIN & HALL, P.A., Wilmington, DE; Bonnie Fletcher Price, Dustin M. Knight, Jennifer Volk-Fortier, COOLEY, LLP, Washington, D.C.; Reuben H. Chen, Juan Pablo Gonzalez, Elizabeth L. Stameshkin, COOLEY, LLP, Palo Alto, CA; Frank Pietrantonio, COOLEY, LLP, Reston, VA; Erik B. Milch, PROSKAUER ROSE, LLP, Washington, D.C., Attorneys for Plaintiff/Counter-Defendant. John G. Day, Andrew C. Mayo, ASHBY & GEDDES, Wilmington, DE; Calvin P. Griffith, Kenneth S. Luchesi, Patrick J. Norton, Robert Breetz, T. Kaitlin Crowder, Thomas S. Koglman, JONES DAY, Cleveland, OH, Attorneys for Defendant/Counter-Plaintiff.

eee te 2025

Before me is the issue of claim construction of two terms in U.S. Patent No. 7,846,207 (“the ’207 patent”) (D.I. 309 at 4-17 of 141, Ex. 1). The parties submitted a Joint Claim Construction Chart (D.I. 303) and Joint Interference Claim Construction Brief. (D.I. 308). I heard oral argument on November 21, 2024. (D.I. 325). I have considered the briefing and oral argument. I BACKGROUND RSB Spine asserted claims of infringement of U.S. Patent No. 9,713,537 (“the *537 patent”) against DePuy.! (D.I. 10 at 1), DePuy asserted an interference counterclaim between the °537 patent and its own patent, U.S. Patent No. 7,846,207 (“the ’207 patent”), in an amended answer (D.I. 16 at 39-42) and again in a second amended answer. (D.I. 41 at 46-55). RSB Spine filed a motion for summary judgment of no interference. (D.I. 174). I deferred a decision on that summary judgment motion until after the jury trial. (D.I. 218). At trial, a jury rendered a verdict for RSB Spine, finding the °537 patent not invalid and finding infringement by DePuy. (D.I. 276). Following the trial, I determined that the interference issue needed to be resolved before entry of a final judgment. (D.I. 292). RSB Spine filed a motion to dismiss the interference counterclaim as moot in view of arguments and evidence presented at trial. (D.I. 297). I denied RSB Spine’s motion to dismiss the interference counterclaim as to the °537 patent. (D.I. 311).

! Plaintiff also asserted infringement of U.S. Patent No. 6,984,234 (“the °234 patent”). I found the asserted claims of the patent invalid as anticipated at summary judgment. (D.I. 236). 2 1 dismissed Defendant’s interference counterclaim as to the °234 patent as moot. (D.I. 311 at

DePuy’s ’207 patent relates to intervertebral implants. (°207 patent at 1:13-14). The priority date of the °207 patent appears to be February 6, 2003. (207 patent at 1:7; D.I. 16 at 36, q 23). I have scheduled a trial on the interference claim. I need to resolve two claim construction disputes for terms in the ’207 patent. Il. LEGAL STANDARD “Tt is a bedrock principle of patent law that the claims of a patent define the invention to which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (en banc) (internal quotation marks omitted). “‘[T]here is no magic formula or catechism for conducting claim construction.’ Instead, the court is free to attach the appropriate weight to appropriate sources ‘in light of the statutes and policies that inform patent law.’” SoftView LLC v. Apple Inc., 2013 WL 4758195, at *1 (D. Del. Sept. 4, 2013) (alteration in original) (quoting Phillips, 415 F.3d at 1324). When construing patent claims, a court considers the literal language of the claim, the patent specification, and the prosecution history. Markman v. Westview Instruments, Inc., 52 F.3d 967, 977-80 (Fed. Cir. 1995) (en banc), aff'd, 517 U.S. 370 (1996). Of these sources, “the specification is always highly relevant to the claim construction analysis. Usually, it is dispositive; it is the single best guide to the meaning of a disputed term.” Phillips, 415 F.3d at 1315 (internal quotation marks omitted). “While claim terms are understood in light of the specification, a claim construction must not import limitations from the specification into the claims.” Deere & Co. v. Bush Hog, LLC, 703 F.3d 1349, 1354 (Fed. Cir. 2012) (citing Phillips, 415 F.3d at 1323). “(T]he words of a claim are generally given their ordinary and customary meaning. . . . [Which is] the meaning that the term would have to a person of ordinary skill in the art in

question at the time of the invention, i.e., as of the effective filing date of the patent application.” Id. at 1312-13 (citations and internal quotation marks omitted). “[T]he ordinary meaning of a claim term is its meaning to [an] ordinary artisan after reading the entire patent.” Jd. at 1321 (internal quotation marks omitted). “In some cases, the ordinary meaning of claim language as understood by a person of skill in the art may be readily apparent even to lay judges, and claim construction in such cases involves little more than the application of the widely accepted meaning of commonly understood words.” /d. at 1314. When a court relies solely upon the intrinsic evidence—the patent claims, the specification, and the prosecution history—the court’s construction is a determination of law. See Teva Pharms. USA, Inc. v. Sandoz, Inc., 574 U.S. 318, 331 (2015). The court may also make factual findings based upon consideration of extrinsic evidence, which “consists of all evidence external to the patent and prosecution history, including expert and inventor testimony, dictionaries, and learned treatises.” Phillips, 415 F.3d at 1317-19 (quoting Markman, 52 F.3d at 980). Extrinsic evidence may assist the court in understanding the underlying technology, the meaning of terms to one skilled in the art, and how the invention works. /d. Extrinsic evidence, however, is less reliable and less useful in claim construction than the patent and its prosecution history. Jd. Ill. CONSTRUCTION OF DISPUTED TERMS The parties agree that Claim 1 of the ’207 patent is representative for the purpose of claim construction.? That claim states: 1. An intervertebral implant for insertion into an intervertebral disc space between endplates of adjacent vertebral bodies, the implant comprising:

3 Claims 2 through 37 are dependent on Claim 1. (°207 patent at 6:59-8:46).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
John D. Watts v. Xl Systems, Inc.
232 F.3d 877 (Federal Circuit, 2000)
Altiris, Inc. v. Symantec Corp., Defendant-Cross
318 F.3d 1363 (Federal Circuit, 2003)
Deere & Co. v. Bush Hog, LLC
703 F.3d 1349 (Federal Circuit, 2012)
Richard Williamson v. Citrix Online, LLC
792 F.3d 1339 (Federal Circuit, 2015)
Indacon, Inc. v. Facebook, Inc.
824 F.3d 1352 (Federal Circuit, 2016)
Zeroclick, LLC v. Apple Inc.
891 F.3d 1003 (Federal Circuit, 2018)
Irdeto Access, Inc. v. Echostar Satellite Corp.
383 F.3d 1295 (Federal Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
RSB Spine, LLC v. DePuy Synthes Sales, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/rsb-spine-llc-v-depuy-synthes-sales-inc-ded-2025.